Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Schizophrenia
100%
At-risk Mental State
72%
Schizophrenic Patients
48%
Psychosis
48%
Healthy Controls
44%
Clinical High Risk for Psychosis (CHR-P)
37%
Patients with Schizophrenia
33%
Schizophrenia Spectrum Disorders
26%
First-episode Psychosis
25%
Individuals at Risk
22%
Magnetic Resonance Imaging Study
21%
Orbitofrontal Cortex
21%
Heschl's Gyrus
19%
Local Gyrification Index
19%
Brain Gyrification
18%
Major Depressive Disorder
17%
Cognitive Function
16%
Sulcogyral Pattern
15%
Structural Magnetic Resonance Imaging (sMRI)
15%
Duplication Pattern
15%
Socio-cognitive
14%
Gyrification
14%
Orbitofrontal
14%
Neurodevelopmental
14%
Vulnerability
14%
Sulcus
14%
MRI Study
14%
Cortical Thickness
13%
Insular Cortex
13%
Psychotic Disorders
13%
Schizotypal Disorder
12%
Psychosis Onset
11%
Clinical Characteristics
11%
Bipolar Disorder
10%
Surface Morphology
10%
Olfactory Sulcus
10%
Pineal Gland Volume
10%
Cognitive Impairment
10%
Clinical High Risk
9%
Duplication
9%
Social Functioning
9%
Neurodevelopmental Markers
9%
Brief Assessment of Cognition in Schizophrenia
9%
Rating Scales
9%
Polymorphism
8%
Major Psychiatric Disorders
8%
Antipsychotic-free
8%
Mismatch Negativity
8%
Olfactory Sulcus Depth
8%
Symptom Severity
8%
Neuroscience
Magnetic Resonance Imaging
48%
Gyri
36%
Gyrification
34%
Orbitofrontal Cortex
26%
Cognitive Function
22%
Negative Syndrome
22%
Cognitive Disorders
20%
Magnetic Resonance Imaging
19%
Major Depressive Disorder
18%
Psychosis
17%
Schizotypal Disorder
15%
Structural Magnetic Resonance Imaging
15%
Insular Cortex
14%
Positive Syndrome
13%
Pineal Gland
13%
Nerve Cell Differentiation
12%
Schizophrenia Spectrum Disorder
12%
Antipsychotic
11%
Bipolar Disorder
11%
Thalamus
8%
Globus pallidus
8%
Mismatch Negativity
8%
Gray Matter
7%
Planum Temporale
6%
Depression
6%
Lateral Ventricle
5%
Schizophrenia
5%
Fatty Acids
5%
Hippocampus
5%
Pervasive Developmental Disorder
5%